Clinical Trial

Measurement Of NT-proBNP to Predict Outcomes in Surgery

Study acronym: MOBOS
Recruiting
View on ClinicalTrials.gov →
Summary
The team is investigating whether N-terminal pro B-type natriuretic peptide (NT-proBNP) and other cardiac markers are useful for predicting outcomes for patients undergoing vascular surgery. By measuring NT-proBNP before and after surgery, the investigators may be able to determine which patients are at risk of an adverse outcome, such as a heart attack or death.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2019-07-08; most recent amendment 2026-06-05.
Status change: Suspended → Recruiting 2026-06-05
Status change: Recruiting → Suspended 2023-12-18
Status change: Not Yet Recruiting → Recruiting 2019-11-06
Trial Details
NCT Number NCT04014647
Lead Sponsor Norfolk and Norwich University Hospitals NHS Foundation Trust
Conditions Vascular Surgical Procedure
Enrollment 200 participants
Start Date 2019-09-05
Primary Completion 2029-09-05 (estimated)
Study Completion 2029-09-05 (estimated)
Updated on ClinicalTrials.gov 2026-06-08